Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
11.33
+1.57 (16.09%)
At close: Sep 17, 2025, 4:00 PM EDT
11.49
+0.16 (1.41%)
After-hours: Sep 17, 2025, 5:47 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Pharmaceutical
1.41M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
-58.15%
Log In
Log In
Log In
Log In
Upgrade
License and Other
516.00K
Log In
Log In
Log In
Log In
Upgrade
License and Other Growth
-96.49%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
1.92M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-89.34%
Log In
Log In
Log In
Log In
Upgrade